SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Medicine
[키워드] Alter
amino acid substitution
antibody
approved
B.1.1.529
B.1.351
B.1.617.2
convalescent plasma
COVID-19 infection
D614G
diagnostics
disease severity
Effectiveness
evade
Factor
Impact
Mutation
mutation rate
mutations
N501Y
natural immunity
non-structural protein
omicron
P.1
prevalent
SARS-CoV-2
SARS-CoV-2 variant
Specific
Spike protein
the SARS-CoV-2
the SARS-CoV-2 genome
the spike protein
Therapeutics
therapy
Transmissibility
Vaccine
Vaccines
variant
variants of concern
variants of interest
virulence
virus
VoC
VOCs
WHO
[DOI] 10.3389/fmed.2022.815389 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2022.815389 PMC 바로가기 [Article Type] Medicine